Back to the main directory
Recommendations / Equity
- Espresso | HHLA | Reduce | Guidance hike largely reflected in consensus by Kepler Cheuvreux
- Espresso | AkzoNobel | Hold | Boards reject third PPG proposal by Kepler Cheuvreux
- Espresso | Banca Mediolanum | Buy | Upgrade to Buy by Kepler Cheuvreux
- Espresso | Deutsche Lufthansa | Hold | Upgrade to Hold, TP up to EUR16.7 by Kepler Cheuvreux
- Espresso | Sodexo | Buy | North American roadshow feedback by Kepler Cheuvreux
- Espresso | Ratos | Buy | Solid improvements in Aibel and Bisnode by Kepler Cheuvreux
- Espresso | Umicore | Hold | Next phase of RBM expansion by Kepler Cheuvreux
- Espresso | Proximus | Reduce | Strong start but medium-term headwinds are still there by Kepler Cheuvreux
- Espresso | William Demant | Buy | Up with Opn by Kepler Cheuvreux
- Espresso | Boliden | Hold | Weaker earnings in Smelters, still waiting for higher grades in Aitik by Kepler Cheuvreux
- Espresso | RCS MediaGroup | Buy | Q1 results ahead of estimates, TP lifted to EUR1.65 by Kepler Cheuvreux
- Espresso | AT&S | Hold | TP cut after FY results by Kepler Cheuvreux
- Espresso | Adecco | Buy | Multiple expansion should continue by Kepler Cheuvreux
- Espresso | Rubis | Buy | This time for Africa, TP up to EUR110 by Kepler Cheuvreux
- Espresso | Campari | Hold | Q1 beat and better than expected patent box, EPS/TP up by Kepler Cheuvreux
- Espresso | Genomic Vision | Buy | A lame start! by Kepler Cheuvreux
- Espresso | Compass | Hold | Solid and shareholder friendly by Kepler Cheuvreux
- Espresso | Carl Zeiss Meditec | Buy | TP up from EUR42 to EUR48.5 - three reasons why we reiterate Buy by Kepler Cheuvreux
- Espresso | NORMA Group | Buy | Still on track by Kepler Cheuvreux
- Espresso | Roche | Hold | The show must go on, despite bladder cancer hitch by Kepler Cheuvreux
- Espresso | Altarea-Cogedim | Hold | Solid development performance again by Kepler Cheuvreux
- Espresso | Geox | Buy | Q1 in line, reassuring A/W backlog, EPS/TP raised, upgrade to Buy by Kepler Cheuvreux
- Espresso | Biotest AG | Hold | Weak Q1 penalised by albumin issues, we cut our TP by Kepler Cheuvreux
- Espresso | IREN | Buy | A good start by Kepler Cheuvreux
- Espresso | Mediobanca | Hold | Numbers up, Hold remains by Kepler Cheuvreux
- Espresso | Daimler | Hold | Solid, but unexciting situation by Kepler Cheuvreux
- Espresso | Euler Hermes | Hold | COR of 78.4% in Q1, slightly better by Kepler Cheuvreux
- Espresso | FinecoBank | Buy | Q1 in line but high quality net inflows in April by Kepler Cheuvreux
- Espresso | Banca Generali | Buy | Good earnings quality, impressive net inflows by Kepler Cheuvreux
- Espresso | Bayer | Hold | Monsanto fears are receding by Kepler Cheuvreux
- Espresso | SSP Group | Hold | Focus on organic growth and new markets, EPS/TP update by Kepler Cheuvreux
- Espresso | Almirall | Buy | Fine-tuning post Q1 by Kepler Cheuvreux
- Espresso | BPER | Buy | Estimate and TP cut after mixed Q1 by Kepler Cheuvreux
- Espresso | Lundin Mining | Buy | Attractive opportunity following share price weakness by Kepler Cheuvreux
- Espresso | Air France-KLM | Hold | Upgrade to Hold, TP raised to EUR9.6 by Kepler Cheuvreux
- Espresso | Sligro | Buy | Heineken deal brings five benefits by Kepler Cheuvreux
- Espresso | IGD | Buy | Strong set of Q1 results, TP to EUR1.0 by Kepler Cheuvreux
- Espresso | Groupe Eurotunnel | Buy | Refinancing floating rate debt by Kepler Cheuvreux
- Espresso | Natixis | Hold | Perfect, and priced as such by Kepler Cheuvreux
- Espresso | Prosegur | Reduce | Q1 EBIT in line by Kepler Cheuvreux
- Espresso | De Longhi | Hold | Q1 in line, sound outlook confirmed by Kepler Cheuvreux
- Espresso | A2A | Hold | Strong results, TP raised by Kepler Cheuvreux
- Espresso | HERA | Buy | Another increase by Kepler Cheuvreux
- Espresso | Maire Tecnimont | Hold | Strong release and confidence for the rest of the year. by Kepler Cheuvreux
- Espresso | Legrand | Hold | Strong start to the year – raising estimates and target price by Kepler Cheuvreux
- Espresso | AXA | Buy | Big news, little change to numbers by Kepler Cheuvreux
- Espresso | ElringKlinger | Buy | Increased confidence in the story by Kepler Cheuvreux
- Espresso | ForFarmers | Hold | Q1 trading in line by Kepler Cheuvreux
- Espresso | Mondadori | Hold | Worse Q1 but likely revision on EBITDA 2019 target after disposals by Kepler Cheuvreux
- Espresso | Durr | Buy | Still on track after strong Q1 by Kepler Cheuvreux